-
公开(公告)号:US12071635B2
公开(公告)日:2024-08-27
申请号:US15516731
申请日:2015-10-05
申请人: Assistance Publique-Hopitaux de Paris , Fondation Imagine-Institut Des Maladies Genetiques , Universtie Paris Descartes , Institut National de la Sante et de la Recherche Medicale (INSERM)
发明人: Marina Cavazzana , Isabelle André , Chantal Lagresle-Peyrou , Salima Hacein-Bey-Abina , Christian Reimann , Corinne De Chappedelaine , Emmanuelle Six
IPC分类号: C12N5/00 , C12N5/0783
CPC分类号: C12N5/0636 , C12N2501/42 , C12N2502/1114 , C12N2506/11 , C12N2533/50 , C12N2533/52
摘要: The invention relates to the field of cell therapy and to an in vitro method for generating T-cell progenitors, comprising the step of exposing CD34+ cells in a medium containing a Notch ligand, a soluble domain of the Delta-like ligand 4, joined to an Fc region of a protein IgG, in the presence of a fragment of fibronectin comprising the motifs RGDS and CS-1 and a heparin-binding domain.